Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.9%

1 terminated/withdrawn out of 53 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

3 trials in Phase 3/4

Results Transparency

25%

3 of 12 completed trials have results

Key Signals

20 recruiting3 with results

Enrollment Performance

Analytics

N/A

11(45.8%)

Phase 2

8(33.3%)

Phase 4

2(8.3%)

Early Phase 1

2(8.3%)

Phase 3

1(4.2%)

24Total

N/A(11)

Phase 2(8)

Phase 4(2)

Early Phase 1(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (53)

Showing 20 of 53 trials

NCT07485842Phase 4Not Yet Recruiting

FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis

Role: lead

NCT06628531Recruiting

ALI & Pulmonary HA Deposition After SAH

Role: lead

NCT07393685Not Yet Recruiting

Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD

Role: lead

NCT07379463Recruiting

Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases

Role: lead

NCT06949670Recruiting

Alpha-Synuclein PET/CT in Various α-Syn-Related Disease

Role: lead

NCT04928534Completed

Cohort Study of Blood Biomarkers for TES

Role: lead

NCT07306598Recruiting

[18F]NIDF PET Imaging in Tau-related Diseases

Role: lead

NCT07288749Phase 3Not Yet Recruiting

Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

Role: collaborator

NCT07232459Recruiting

[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis

Role: lead

NCT07130565Recruiting

Pan-Amyloid PET/CT in Various Amyloid-Related Disease

Role: lead

NCT06690970Recruiting

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

Role: lead

NCT06725706Recruiting

Beta Amyloid PET/CT in Various Aβ-Related Disease

Role: lead

NCT06913153Completed

Tianjin Diabetes and Health Cohort Study

Role: lead

NCT06951984Recruiting

Hydroxyephedrine PET/CT in Sympathetic Nervous System Disease

Role: lead

NCT05680844Completed

Peripheral Treg Cell Senescence & Serum Total Cholesterol Level

Role: lead

NCT06690736Not ApplicableRecruiting

Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases

Role: lead

NCT06690957Recruiting

Somatostatin Receptor PET/CT in SSTR-Related Disease Patients

Role: lead

NCT06688071Recruiting

FAPI PET/CT in Various FAP-Related Disease Patients

Role: lead

NCT06725719Recruiting

Translocator Protein PET/CT in Various TSPO-Related Disease

Role: lead

NCT06690983Recruiting

Tau PET/CT in Various Tau-Related Disease Patients

Role: lead